Drug Topics November 13, 2024
Brian Nowosielski

Selina Coleman, JD, Partner in Life Sciences Health Industry Group at Reed Smith LLP, discussed recent developments in Supreme Court decisions impacting pharmacy operations.

Addressing recent Supreme Court decisions and developments within the pharmacy industry, a pharmacy law expert discussed how these decisions impact pharmacies’ ability to dispense medication and agency roles in enforcing regulatory standards. From Loper Bright overturning the Chevron deference decision to the subsequent cases that ironed out Loper Bright, they discussed macro-level developments in the Supreme Court and the implications these decisions have on pharmacies.

At the American Society of Pharmacy Law’s 50th Developments in Pharmacy Law Seminar, Selina Coleman, JD, Partner in Life Sciences Health Industry Group at Reed Smith LLP, hosted a session titled...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights
Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin
What might a Trump administration mean for the Biosecure Act?
Q&A: Reducing Mental Health Stigma Starts in Pharmacies
Flagship, Pfizer alliance yields two more startup deals

Share This Article